Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
20:59:59 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.6000 CAD | -1.64% |
|
0.00% | -14.29% |
| Market Cap | 108M 95.2M 89.39M 81.85M 153M 10.38B 154M 1.07B 416M 5.29B 407M 398M 17.16B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 124M 109M 102M 93.4M 174M 11.84B 176M 1.23B 475M 6.04B 464M 454M 19.58B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -1.64% | ||
| Current month | -3.23% | ||
| 1 month | -9.09% | ||
| 3 months | -3.23% | ||
| 6 months | +44.58% | ||
| Current year | -14.29% |
| 1 week | 0.59 |  | 0.62 |
| 1 month | 0.58 | | 0.67 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.3 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 31/12/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.64% | 0.00% | -6.25% | +87.50% | 108M | |
| +0.08% | +1.22% | -11.66% | -3.31% | 13.67B | |
| -0.21% | +1.24% | -31.49% | -55.97% | 4.84B | |
| +0.66% | -0.13% | -2.44% | -5.21% | 4.36B | |
| -0.77% | +1.71% | -5.04% | -32.43% | 3.88B | |
| +0.83% | +3.84% | -20.97% | +5.42% | 3.49B | |
| -0.69% | -4.02% | -2.69% | -4.84% | 3.4B | |
| -0.43% | -0.57% | -11.58% | +2.36% | 3.11B | |
| -0.61% | +0.48% | -20.48% | -17.67% | 2.29B | |
| -1.96% | +2.36% | -26.09% | -21.86% | 1.69B | |
| Average | -0.47% | +0.97% | -13.87% | -4.60% | 4.08B | |
| Weighted average by Cap. | -0.14% | +0.71% | -13.52% | -12.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.73M 22.28M 20.4M 38.1M 2.59B 38.38M 268M 104M 1.32B 101M 99.23M 4.28B | 32.43M 28.49M 26.74M 24.49M 45.73M 3.1B 46.06M 322M 124M 1.58B 122M 119M 5.13B |
| Net income | -11.3M -9.93M -9.32M -8.54M -15.94M -1.08B -16.06M -112M -43.39M -552M -42.43M -41.52M -1.79B | 1.73M 1.52M 1.43M 1.31M 2.44M 166M 2.46M 17.15M 6.64M 84.49M 6.49M 6.35M 274M |
| Net Debt | 3.7M 3.25M 3.06M 2.8M 5.22M 355M 5.26M 36.73M 14.22M 181M 13.91M 13.61M 586M | 15.3M 13.44M 12.62M 11.55M 21.58M 1.46B 21.73M 152M 58.73M 747M 57.43M 56.19M 2.42B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | CA$0.6000 | -1.64% | 5,000 |
| 22/09/26 | CA$0.6100 | +3.39% | 9,550 |
| 21/09/26 | CA$0.5900 | 0.00% | 8,000 |
| 18/09/26 | CA$0.5900 | -1.67% | 9,000 |
| 17/09/26 | CA$0.6000 | 0.00% | 6,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
